Correlation Between Cardio Diagnostics and Revelation Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Revelation Biosciences, you can compare the effects of market volatilities on Cardio Diagnostics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Revelation Biosciences.

Diversification Opportunities for Cardio Diagnostics and Revelation Biosciences

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cardio and Revelation is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Revelation Biosciences go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Revelation Biosciences

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 1.07 times more return on investment than Revelation Biosciences. However, Cardio Diagnostics is 1.07 times more volatile than Revelation Biosciences. It trades about -0.35 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.6 per unit of risk. If you would invest  87.00  in Cardio Diagnostics Holdings on November 2, 2024 and sell it today you would lose (42.00) from holding Cardio Diagnostics Holdings or give up 48.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Revelation Biosciences

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Cardio Diagnostics displayed solid returns over the last few months and may actually be approaching a breakup point.
Revelation Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Revelation Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cardio Diagnostics and Revelation Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Revelation Biosciences

The main advantage of trading using opposite Cardio Diagnostics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.
The idea behind Cardio Diagnostics Holdings and Revelation Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance